BRIGHT BEAD
LIVE

Serial Number

79143704

Owner

QIAGEN GMBH

Attorney

G MATHEW LOMBARD

Filing Date

Sep 19, 2013

Add to watchlist:

No watchlists yet
View on USPTO

BRIGHT BEAD Trademark

Serial Number: 79143704 • Registration: 4634911

BRIGHT BEAD is a trademark filed by QIAGEN GMBH on September 19, 2013. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics). The application is currently registered and active.

Owner Contact Info

QIAGEN GMBH (212 trademarks)

HILDEN D-4010 , DE

Entity Type: 03

Trademark Details

Filing Date

September 19, 2013

Registration Date

November 11, 2014

Published for Opposition

August 26, 2014

Cancellation Date

September 18, 2023

Goods & Services

Scientific apparatus, instruments and equipment for research and analysis purposes, as well as laboratory apparatuses, measuring apparatuses and instruments for the use of products for human medical and veterinary medical diagnostic purposes, namely, for sample preparation, as well as for the labeling, separation, identification, quantification, isolation, purification, amplification and/or analysis of biopolymers, namely, nucleic acids, proteins, macromolecules and biologically active substances, namely, nucleic acids from biological or biochemical sample material, in the nature of tubes, vessels, columns, sample holders, boxes for incubation of biological or biochemical samples, filter devices for biological or biochemical samples, as far as included in this class

Diagnostics agents, reagents, substances and/or preparations for medical purposes; products for human medical and veterinary medical purposes in the nature of diagnostics, namely, for sample preparation, as well as for the labeling, separation, identification, quantification, isolation, purification, amplification and/or analysis of biopolymers, namely, nucleic acids, proteins, macromolecules and biologically active substances in the nature of assays; chemical, biochemical and biotechnological products, namely, medical reagents and solvents for sample preparation, as well as for methods for labeling, separating, identifying, quantifying, isolating, purifying, amplifying and/or analyzing biopolymers, namely, nucleic acids, proteins, macromolecules and biologically active substances in the nature of assays for diagnostic purposes; kits comprising products for human medical and veterinary medical diagnostic purposes, namely, for sample preparation, as well as for the labeling, separation, identification, quantification, isolation, purification, amplification and/or analysis of biopolymers, namely, nucleic acids, proteins, macromolecules and biologically active substances in the nature of nucleic acids from biological or biochemical sample material

Chemical, biochemical, and biotechnological products, namely, chemicals and biochemicals for industrial and scientific purposes; scientific reagents and solvents for sample preparation, as well as for methods for labeling, separating, identifying, quantifying, isolating, purifying, amplifying and/or analyzing biopolymers, namely, nucleic acids, proteins, macromolecules and biologically active substances in the nature of assays; kits comprising chemical products, namely, chemicals for sample preparation, as well as for the labeling, separation, identification, quantification, isolation, purification, amplification and/or analysis of biopolymers, namely, nucleic acids, proteins, macromolecules and biologically active substances, namely, nucleic acids from biological or biochemical sample material

Filing History

NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Apr 14, 2024 DENC
NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Apr 14, 2024 DENA
DEATH OF INTERNATIONAL REGISTRATION
Apr 14, 2024 DETH
TOTAL INVALIDATION PROCESSED BY THE IB
Jul 17, 2022 INNT
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
May 23, 2022 INTS
INVALIDATION PROCESSED
May 23, 2022 INPC
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Jan 28, 2022 INTR
CANCELLED SECTION 71
May 28, 2021 C71T
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Nov 11, 2019 REM3
NEW REPRESENTATIVE AT IB RECEIVED
Oct 18, 2018 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
May 2, 2015 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Apr 14, 2015 FICS
FINAL DISPOSITION PROCESSED
Apr 14, 2015 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Feb 11, 2015 FICR
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Dec 29, 2014 TCCA
REGISTERED-PRINCIPAL REGISTER
Nov 11, 2014 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 26, 2014 NPUB
PUBLISHED FOR OPPOSITION
Aug 26, 2014 PUBO
NOTIFICATION PROCESSED BY IB
Aug 22, 2014 GPNX
NEW REPRESENTATIVE AT IB RECEIVED
Aug 22, 2014 NREP
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Aug 6, 2014 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Aug 6, 2014 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 6, 2014 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Jul 24, 2014 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 24, 2014 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 3, 2014 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 3, 2014 CRFA
ASSIGNED TO LIE
Jun 30, 2014 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 19, 2014 TROA
REFUSAL PROCESSED BY IB
Apr 4, 2014 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 20, 2014 RFCS
REFUSAL PROCESSED BY MPU
Mar 20, 2014 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 20, 2014 RFCR
NON-FINAL ACTION WRITTEN
Mar 19, 2014 CNRT
APPLICATION FILING RECEIPT MAILED
Mar 18, 2014 MAFR
ASSIGNED TO EXAMINER
Mar 14, 2014 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 14, 2014 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Mar 13, 2014 REPR